Volume 19, Number 1—January 2013
Concurrent Tuberculosis and Influenza, South Korea
Highlight and copy the desired format.
|EID||Noh J, Lee J, Choi W, Song J, Seo Y, Kim I, et al. Concurrent Tuberculosis and Influenza, South Korea. Emerg Infect Dis. 2013;19(1):165-167. https://dx.doi.org/10.3201/eid1901.111613|
|AMA||Noh J, Lee J, Choi W, et al. Concurrent Tuberculosis and Influenza, South Korea. Emerging Infectious Diseases. 2013;19(1):165-167. doi:10.3201/eid1901.111613.|
|APA||Noh, J., Lee, J., Choi, W., Song, J., Seo, Y., Kim, I....Kim, W. (2013). Concurrent Tuberculosis and Influenza, South Korea. Emerging Infectious Diseases, 19(1), 165-167. https://dx.doi.org/10.3201/eid1901.111613.|
To the Editor: The concurrence of active pulmonary tuberculosis (TB) and influenza in immunocompetent hosts is rarely reported. Such concurrence could distract clinicians from diagnosing TB during an influenza epidemic. We describe 7 cases of concurrent active pulmonary TB and influenza A(H1N1)pdm09 virus infection in South Korea.
At 2 teaching hospitals in Seoul, medical records were reviewed retrospectively. Among the 12,196 patients for whom A(H1N1)pdm09 infection was confirmed by real-time reverse transcription PCR from May 2009 through May 2011, a total of 7 (0.06%) were co-infected with newly diagnosed active pulmonary TB (Table). Patients who had a history of TB diagnosis were excluded.
Among the 7 co-infected patients, 6 (85.7%) were <30 years of age. All but 1 patient, who had colon cancer, had been previously healthy. No patients had diabetes mellitus or HIV infection. One patient was a current smoker. For 5 patients, pulmonary TB was diagnosed within 1 week from the date of influenza diagnosis; initial chest radiographic findings were suggestive of active TB or pneumonia. Another 2 patients, for whom radiographic examination was not performed at the first visit, experienced worsening cough and blood-tinged sputum after improvement of influenza; laboratory tests for TB were performed, and pulmonary TB was diagnosed 17 days after the date of influenza diagnosis. For 4 patients, computed tomography of the chest was performed, and multiple nodular lesions, cavities, and tree-in-bud appearance were found. Lymphopenia at initial visit was detected in 2 patients. All Mycobacterium tuberculosis isolates were sensitive to anti-TB drugs, and clinical outcomes were good for all patients.
For persons infected with M. tuberculosis, lifetime risk for development of active TB is 5%–10%; this risk increases for those with immunocompromising conditions (1). One study reported that pulmonary TB was a risk factor for A(H1N1)pdm09 infection (2). However, the concurrence of influenza and pulmonary TB has been reported only a few times, and the findings have been mostly descriptive and somewhat contradictory. An old report, from 1919, describes TB diagnoses for patients who were not recovered completely from influenza pneumonia (3). During 1957–1958, Löfgren and Callans (4) observed 46 patients with newly detected TB that had been diagnosed shortly after Asian influenza; among them, 4 had a history of typical influenza.
In South Africa, among 72 patients who died of A(H1N1)pdm09 infection, 7 also had active TB (5). In Taiwan, TB and A(H1N1)pdm09 infection in a lung cancer patient was reported (6). In Japan, a fatal case of influenza pneumonia combined with Streptococcus pneumoniae and M. tuberculosis infection in a patient with diabetes mellitus was reported (7). Although the 2 patients from Taiwan and Japan had concurrent illnesses, 6 of the 7 patients in our study had been healthy (6,7). Radiographic abnormalities for the patients reported here were similar to those reported for other patients, but more cavitary lesions were found for the patients reported here.
Although it is not clear whether influenza accelerates emergence of TB, some animal studies suggest that influenza-associated TB is possible. In mouse studies, simultaneous injection of tubercle bacilli into the peritoneum and intranasal inoculation with influenza A virus (PR8) resulted in more rapid and extensive development of pulmonary tuberculous lesions than did infection with tubercle bacilli only (8). In a mouse model of chronic infection with M. bovis BCG, acute infection with influenza virus moderately increased the load of acid-fast bacilli in the liver, although this change was not significant (9).
It is possible that temporary suppression of T-cell immunity by A(H1N1)pdm09 virus might alter the course of M. tuberculosis infection. Among influenza patients, CD4+ T cells were depleted and a subset of Th17 cells were preferentially lost at an early stage of infection; Th17 cells that produce proinflammatory cytokine interleukin-17 are associated with a protective immune response (10). Among 4 patients for whom laboratory examination was conducted at initial visit, 2 were lymphopenic. However, individual lymphocyte subsets were not checked, and a functional assay of lymphocytes was not conducted. Further studies of serial quantification and functional assay of lymphocytes at the acute stage of influenza and its effect on host susceptibility to TB in animals and humans are needed.
The concurrence of TB and influenza could be a simple overlap. In 2009, the case notification rate of pulmonary TB in South Korea was 58.2 cases per 100,000 population; in 2010, it was 56.5. However, if influenza actually amplifies TB, TB might be underestimated and missed in influenza patients. Thus, large-scale observational epidemiologic studies on the changing incidence of TB during the influenza postpandemic era are needed. Especially in TB-endemic areas, physicians should consider a concurrent pulmonary TB diagnosis for influenza patients with radiologic abnormalities consistent with TB or with prolonged respiratory symptoms.
This study was supported by a grant from the Korea Healthcare Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea (grant no. A103001).
- Gideon HP, Flynn JL. Latent tuberculosis: what the host “sees”? Immunol Res. 2011;50:202–12 and.
- Puvanalingam A, Rajendiran C, Sivasubramanian K, Ragunanthanan S, Suresh S, Gopalakrishnan S. Case series study of the clinical profile of H1N1 swine flu influenza. J Assoc Physicians India. 2011;59:14–6, 8.
- Tuberculosis after influenza. Cal State J Med. 1919;17:85.
- Löfgren S, Callans A. Asian influenza and pulmonary tuberculosis. Acta Med Scand. 1959;164:523–7 and.
- Archer B, Cohen C, Naidoo D, Thomas J, Makunga C, Blumberg L, Interim report on pandemic H1N1 influenza virus infections in South Africa, April to October 2009: epidemiology and factors associated with fatal cases. Euro Surveill. 2009;14:19369 .
- Tan CK, Kao CL, Shih JY, Lee LN, Hung CC, Lai CC, Coinfection with Mycobacterium tuberculosis and pandemic H1N1 influenza A virus in a patient with lung cancer. J Microbiol Immunol Infect. 2011;44:316–8 and.
- Seki M, Suyama N, Hashiguchi K, Hara A, Kosai K, Kurihara S, A patient with fulminant influenza-related bacterial pneumonia due to Streptococcus pneumoniae followed by Mycobacterium tuberculosis infection. Intern Med. 2008;47:2043–7 and.
- Volkert M, Pierce C, Horsfall FL, Dubos RJ. The enhancing effect of concurrent infection with pneumotropic viruses on pulmonary tuberculosis in mice. J Exp Med. 1947;86:203–14 and.
- Co DO, Hogan LH, Karman J, Heninger E, Vang S, Wells K, Interactions between T cells responding to concurrent mycobacterial and influenza infections. J Immunol. 2006;177:8456–65 .
- Jiang TJ, Zhang JY, Li WG, Xie YX, Zhang XW, Wang Y, Preferential loss of Th17 cells is associated with CD4 T cell activation in patients with 2009 pandemic H1N1 swine-origin influenza A infection. Clin Immunol. 2010;137:303–10 and.
TableCite This Article
Please use the form below to submit correspondence to the authors or contact them at the following address:
Woo Joo Kim, Division of Infectious Diseases, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, 97 Gurodong-gil, Guro-gu, Seoul 152-703, South Korea
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 20, 2012
- Page last updated: December 20, 2012
- Page last reviewed: December 20, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)